IC
MXCT icon

IEQ Capital’s MaxCyte MXCT Stock Holding History

IEQ Capital’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Buy
237,962
+122,762
+107% +$122K ﹤0.01% 1650
2026
Q1 		$80.9K Buy
115,200
+103,075
+850% +$96.2K ﹤0.01% 1816
2025
Q4 		$18.8K Sell
12,125
-8,248
-40% -$13.2K ﹤0.01% 1829
2025
Q3 		$32.2K Buy
20,373
+6,492
+47% +$11.3K ﹤0.01% 1815
2025
Q2 		$30.3K Buy
13,881
+2,804
+25% +$6.79K ﹤0.01% 1785
2025
Q1 		$30.2K Buy
+11,077
New +$43.7K ﹤0.01% 1574

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

IEQ Capital's MXCT Position: Q2 2026 in Review

IEQ Capital increased its MaxCyte (MXCT) stake by 107% in Q2 2026, buying an estimated $122K and bringing the position to 237,962 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #1650.

IEQ Capital first reported a position in MXCT in Q1 2025 and has held it in 6 quarters since. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • IEQ Capital held 237,962 shares of MaxCyte worth $293K as of Q2 2026.
  • IEQ Capital bought 122,762 MaxCyte shares in Q2 2026, an estimated $122K.
  • MaxCyte made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1650 holding.
  • IEQ Capital first reported a position in MaxCyte in Q1 2025 and has held it in 6 quarters since.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.